Table of Contents
| << Previous Issue | May 2009 (Vol: 2009, Issue: 5) | Next Issue >> |
- Section: Business Commentaries
-
Japan on the Move
- Section: Editorial
-
Integrating Data and Analyses of Pharmaceutical and Biotech Deals Information: The New Approach of PharmaDeals
- Section: General
-
SEC Probes Schering-Plough Trades before Merck Deal
- Section: Licensing
-
Oxford BioMedica Handed Back Trovax® and Secures Ocular Disease Deal
-
Strategic Agreement Between Genzyme and Bayer
-
Cornerstone's Strategic Transaction with Chiesi
- Section: Mergers & Acquisitions
-
Sanofi-aventis To Acquire BiPar Sciences
-
Takeda Powers Ahead in Oncology
-
Covidien Acquires VNUS Medical Technologies for US$440 M
- Section: Research & Development
-
Boehringer and Exelixis to Collaborate in Autoimmune Diseases
-
Jubilant Enters into Research Collaboration with AstraZeneca
-
CombinatoRx's Oncology Collaboration with Novartis
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.



RSS